Hudson Bay Capital Management
NVOS

Hudson Bay Capital Management’s Novo Integrated Sciences, Inc. Common Stock NVOS Stock Holding History

Hudson Bay Capital Management’s Portfolio NVOS Stock Details NVOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-252,671
Closed -$508K – 1111
2022
Q4 		$508K Buy
+252,671
New +$869K 0.01% 722

Other funds holding NVOS

VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
AWM
Axxcess Wealth Management Carlsbad, California $6.28B AUM 24.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

Hudson Bay Capital Management's NVOS Position: Q1 2023 in Review

Hudson Bay Capital Management sold out of Novo Integrated Sciences, Inc. Common Stock (NVOS) in Q1 2023, closing a stake of 252,671 shares — an estimated $508K sold.

Hudson Bay Capital Management first reported a position in NVOS in Q4 2022 and held it in 1 quarter. The position peaked at $508K in Q4 2022. 14 funds tracked by Wall St. Rank hold NVOS as of Q1 2023.

  • Hudson Bay Capital Management reported no remaining Novo Integrated Sciences, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Hudson Bay Capital Management sold 252,671 Novo Integrated Sciences, Inc. Common Stock shares in Q1 2023, an estimated $508K.
  • Hudson Bay Capital Management first reported a position in Novo Integrated Sciences, Inc. Common Stock in Q4 2022 and held it in 1 quarter.
  • Hudson Bay Capital Management's Novo Integrated Sciences, Inc. Common Stock position peaked at $508K in Q4 2022.
  • 14 funds tracked by Wall St. Rank held Novo Integrated Sciences, Inc. Common Stock as of Q1 2023.

Based on Hudson Bay Capital Management's 13F filing for Q1 2023, filed 15 May 2023.